An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Maryland Physicians Care (MPC) Selects NantHealth’s Eviti Connect to Validate Treatment For Members with Autoimmune Diseases
Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags
Rhea-AI Summary
NantHealth (NASDAQ: NH) has announced that Maryland Physicians Care (MPC) will utilize its Eviti Connect for Autoimmune Diseases solution. This initiative aims to enhance drug authorization processes for members with chronic autoimmune conditions. The platform will improve visibility into drug costs, support reimbursements, and reduce denials while optimizing patient care.
Dr. Jonathan Keyser, Director of Pharmacy at MPC, emphasized the commitment to provide high-quality healthcare through innovative programs. NantHealth's COO Ron Louks noted that the collaboration aligns with their mission to improve patient care efficiency.
Positive
MPC adopts NantHealth's Eviti Connect for Autoimmune Diseases to enhance medication approval processes.
The platform aims to improve drug cost visibility and reduce denials, benefiting member care.
Negative
None.
Building on a long-term relationship with NantHealth’s Eviti Connect for Oncology, MPC commits to improving member care and managing costs associated with treating autoimmune diseases
MORRISVILLE, N.C.--(BUSINESS WIRE)--
NantHealth, Inc. (NASDAQ: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that Maryland Physicians Care (MPC), an existing customer of the Eviti Connect for Oncology platform, selected NantHealth’s Eviti Connect for Autoimmune Diseases solution as the foundation for MPC’s new industry-leading digital drug authorization program for members living with chronic autoimmune conditions. Eviti Connect for Autoimmune Diseases will enable MPC to gain visibility into drug costs, support proper reimbursements, reduce denials and appeals, and minimize overall cost while increasing patient care.
“We continuously seek innovative ways to serve the people of Maryland by implementing high-quality, value-based, and cost-effective programs that improve care and overall health,” said Dr. Jonathan Keyser, PharmD, MBA, Director of Pharmacy at MPC, A Maryland Managed Care Plan. “We’re thrilled to roll out the Eviti Connect for Autoimmune Diseases platform to our provider network to enhance the medication approval process for members living with autoimmune conditions. Using the platform will help our members access their medications as needed.”
The new agreement allows MPC to extend the knowledge of their clinical teams with independent expertise, streamline authorization workflows for providers and internal staff and confirm that member care complies with medical policy, pharmacy policy, and step therapy requirements.
“At NantHealth, our mission is to help providers and payers expedite the path to appropriate care and reduce wasteful spending, and our collaboration with MPC embodies this mission,” said Ron Louks, Chief Operating Officer at NantHealth. “We are excited to enable MPC’s provider network to efficiently determine treatments that meet plan requirements at the point of care so members can access treatments for autoimmune diseases when needed.”
NantHealth’s Eviti Connect is a software-as-a-service (SaaS), evidence-based decision support and treatment validation platform that gives providers and payers confidence to prescribe and reimburse high-quality, high-value care. It has helped payers and providers navigate the complexities of cancer care and has expanded its focus and targets autoimmune diseases aiming to save time on appeals and expedite optimal patient care while managing payer costs.
For more information about Eviti Connect, visit the NantHealthwebsite.
About NantHealth, Inc.
NantHealth, a member of the NantWorks ecosystem of companies, provides enterprise solutions that help businesses transform complex data into actionable insights. By offering efficient ways to move, interpret, and visualize complex and highly sensitive information, NantHealth enables customers in healthcare, life sciences, logistics, telecommunications and other industries to automate, understand and act on data while keeping it secure and scalable. NantHealth’s product portfolio comprises the latest technology in payer/provider collaboration platforms for real-time coverage decision support (Eviti and NaviNet), and data solutions that provide multi-data analysis, reporting and professional services offerings (Quadris). The OpenNMS Group, Inc., a NantHealth subsidiary, helps businesses monitor and manage network health and performance. For more information, visit nanthealth.com, follow us on Twitter, Facebook, LinkedIn and YouTube, and subscribe to our blog.
Forward Looking Statement
This news release contains certain statements of a forward-looking nature relating to future events or future business performance. Forward-looking statements can be identified by the words “expects,” “anticipates,” “believes,” “intends,” “estimates,” “plans,” “will,” “outlook” and similar expressions. Forward-looking statements are based on management’s current plans, estimates, assumptions and projections, and speak only as of the date they are made. Risks and uncertainties include, but are not limited to: our ability to successfully integrate a complex learning system to address a wide range of healthcare issues; our ability to successfully amass the requisite data to achieve maximum network effects; appropriately allocating financial and human resources across a broad array of product and service offerings; raising additional capital as necessary to fund our operations; our ability to grow the market for our software and data solutions; successfully enhancing our software and data solutions to achieve market acceptance and keep pace with technological developments; customer concentration; competition; security breaches; bandwidth limitations; our ability to integrate The OpenNMS Group, Inc. into our operations; our use and distribution of open source software; our ability to obtain necessary regulatory approvals, certifications and licenses; dependence upon senior management; the need to comply with and meet applicable laws and regulations; unexpected adverse events; and anticipated cost savings. We undertake no obligation to update any forward-looking statement in light of new information or future events, except as otherwise required by law. Forward-looking statements involve inherent risks and uncertainties, most of which are difficult to predict and are generally beyond our control. Actual results or outcomes may differ materially from those implied by the forward-looking statements as a result of the impact of a number of factors, many of which are discussed in more detail in our reports filed with the Securities and Exchange Commission.
About Maryland Physicians Care
Maryland Physicians Care is a local managed care organization owned by Meritus Medical Center, Inc., Western Maryland Health System Corporation, Holy Cross Health, Inc. and St. Agnes Healthcare, Inc. Maryland Physicians Care administers health care services to Maryland’s HealthChoice enrollees. Founded in 1996, Maryland Physicians Care believes in helping its members make good decisions about their health through quality health care services.
What is the new initiative announced by NantHealth on Eviti Connect for Autoimmune Diseases?
NantHealth announced that Maryland Physicians Care will utilize its Eviti Connect for Autoimmune Diseases solution to enhance drug authorization for members with autoimmune conditions.
How will the Eviti Connect platform benefit Maryland Physicians Care members?
The Eviti Connect platform will improve visibility into drug costs, support reimbursements, and reduce denials, thereby enhancing overall patient care.
What is the relationship between NantHealth and Maryland Physicians Care?
NantHealth has a long-term relationship with Maryland Physicians Care, and the new initiative builds upon that partnership to improve member care for autoimmune diseases.
What does NantHealth's Eviti Connect solution aim to achieve?
The Eviti Connect solution aims to expedite the medication approval process, reduce costs, and ensure compliance with medical policies for better patient outcomes.
